"I've never seen anything bigger"

From Legacy Research | Ad

According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".

Watch more here!

BDTX Insider Trading (Black Diamond Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.18%

Insider Buying (Last 12 Months): $152,300.00

Insider Selling (Last 12 Months): $9,827,962.12

Black Diamond Therapeutics Insider Trading History Chart

Black Diamond Therapeutics Share Price & Price History

^$12.71

▲ +0.39 (3.17%)

As of 06/24/2021 06:19 PM ET

Days: 30 | 90 | 365

This Is By Far My #1 Income Stock

From Oxford Club | Ad

This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year. And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.

Click here to get it.

Black Diamond Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$27.42	$111,818.76	12,478
5/3/2021	Christopher D Roberts	Insider	Sell	2,500	$26.64	$66,600.00	5,700
4/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$25.00	$101,950.00	12,478
4/5/2021	Christopher D Roberts	Insider	Sell	2,500	$25.54	$63,850.00	5,700
3/3/2021	Christopher D Roberts	Insider	Sell	2,500	$26.10	$65,250.00
2/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$27.23	$111,043.94	12,478
2/3/2021	Christopher D Roberts	Insider	Sell	2,500	$25.35	$63,375.00	5,700
1/12/2021	Brent Hatzis-Schoch	Insider	Sell	11,578	$34.03	$393,999.34	12,478
1/8/2021	Thomas Leggett	CFO	Sell	3,000	$33.94	$101,820.00	3,000
1/4/2021	Christopher D Roberts	Insider	Sell	2,500	$31.41	$78,525.00	5,700
12/14/2020	Brent Hatzis-Schoch	Insider	Sell	4,078	$34.95	$142,526.10	7,078
12/8/2020	Thomas Leggett	CFO	Sell	3,000	$33.78	$101,340.00	3,000
12/3/2020	Christopher D Roberts	Insider	Sell	2,500	$32.42	$81,050.00	2,500
12/1/2020	David M Epstein	Insider	Sell	12,000	$32.71	$392,520.00	714,923
11/30/2020	Bradley J Phd Bolzon	Director	Sell	10,393	$33.15	$344,527.95	21,825
11/18/2020	Bradley J Phd Bolzon	Director	Sell	536	$33.09	$17,736.24	15,634
11/18/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	473	$33.09	$15,651.57
11/16/2020	Bradley J Phd Bolzon	Director	Sell	200	$33.01	$6,602.00	15,634
11/16/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	177	$33.01	$5,842.77
11/12/2020	Bradley J Phd Bolzon	Director	Sell	15,598	$34.15	$532,671.70	14,132
11/12/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	13,779	$34.15	$470,552.85
11/9/2020	Bradley J Phd Bolzon	Director	Sell	6,300	$33.06	$208,278.00	10,178
11/9/2020	Thomas Leggett	CFO	Sell	3,000	$32.96	$98,880.00	3,000
11/9/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	5,565	$33.06	$183,978.90
11/6/2020	Bradley J Phd Bolzon	Director	Sell	3,100	$33.13	$102,703.00	10,178
11/6/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	2,738	$33.13	$90,709.94
11/4/2020	Bradley J Phd Bolzon	Director	Sell	2,500	$33.14	$82,850.00	10,178
11/4/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	2,208	$33.14	$73,173.12
11/2/2020	David M Epstein	Insider	Sell	12,000	$31.14	$373,680.00	723,923
10/26/2020	Bradley J Phd Bolzon	Director	Sell	8,103	$33.30	$269,829.90	10,178
10/26/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	7,158	$33.30	$238,361.40
10/19/2020	Bradley J Phd Bolzon	Director	Sell	4,233	$33.43	$141,509.19	10,178
10/19/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	3,739	$33.43	$124,994.77
10/16/2020	Bradley J Phd Bolzon	Director	Sell	8,713	$33.57	$292,495.41	10,178
10/16/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	7,697	$33.57	$258,388.29
10/14/2020	Bradley J Phd Bolzon	Director	Sell	5,501	$33.09	$182,028.09	10,178
10/14/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	4,859	$33.09	$160,784.31
10/12/2020	Bradley J Phd Bolzon	Director	Sell	400	$33.11	$13,244.00	10,178
10/12/2020	Brent Hatzis-Schoch	Insider	Sell	4,078	$32.70	$133,350.60	7,078
10/12/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	353	$33.11	$11,687.83
10/8/2020	Bradley J Phd Bolzon	Director	Sell	18,425	$33.47	$616,684.75	10,178
10/8/2020	Thomas Leggett	CFO	Sell	3,000	$33.53	$100,590.00	3,000
10/8/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	16,276	$33.47	$544,757.72
10/6/2020	Bradley J Phd Bolzon	Director	Sell	18,090	$33.26	$601,673.40	8,729
10/6/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	15,980	$33.26	$531,494.80
10/5/2020	Christopher D Roberts	Insider	Sell	2,500	$31.28	$78,200.00	2,500
10/1/2020	David M Epstein	Insider	Sell	12,000	$30.33	$363,960.00	732,923
9/30/2020	Robert Alexander Ingram	Director	Buy	5,000	$30.46	$152,300.00	5,000
9/14/2020	Brent Hatzis-Schoch	Insider	Sell	4,078	$31.04	$126,581.12	7,078
9/14/2020	Thomas Leggett	CFO	Sell	3,000	$31.00	$93,000.00	3,000
9/3/2020	Christopher D Roberts	Insider	Sell	2,500	$29.59	$73,975.00	2,500
8/10/2020	Bradley J Phd Bolzon	Director	Sell	6,217	$33.04	$205,409.68	1,491
8/10/2020	Versant Venture Capital Vi, L.	Major Shareholder	Sell	5,492	$33.04	$181,455.68
2/3/2020	James E Flynn	Insider	Buy	400,000	$38.00	$15,200,000.00
2/3/2020	Rajeev M Shah	Director	Buy	1,000,000	$37.88	$37,880,000.00
2/3/2020	Versant Venture Capital Vi, L.	Major Shareholder	Buy	894,736	$37.88	$33,892,599.68

Insider Buying at Black Diamond Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Black Diamond Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Black Diamond Therapeutics (NASDAQ:BDTX)

80.25% of Black Diamond Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Squarepoint Ops LLC	59,863	$1.45M	0.0%	+96.7%	0.166%
5/18/2021	Millennium Management LLC	140,630	$3.41M	0.0%	-18.9%	0.389%
5/18/2021	State of Wisconsin Investment Board	24,400	$0.59M	0.0%	-4.3%	0.067%
5/18/2021	Morgan Stanley	12,788	$0.31M	0.0%	-88.5%	0.035%
5/18/2021	Cubist Systematic Strategies LLC	20,489	$0.50M	0.0%	+7.5%	0.057%
5/18/2021	Jane Street Group LLC	11,621	$0.28M	0.0%	-37.6%	0.032%
5/18/2021	Silverarc Capital Management LLC	6,000	$0.15M	0.1%	N/A	0.017%
5/17/2021	Deerfield Management Company L.P. Series C	1,047,599	$25.42M	0.5%	+30.5%	2.897%
5/17/2021	PDT Partners LLC	67,744	$1.64M	0.1%	+171.0%	0.187%
5/17/2021	Royal Bank of Canada	2,194	$53K	0.0%	+456.9%	0.006%
5/17/2021	Polar Capital Holdings Plc	553,774	$13.44M	0.1%	+19.1%	1.531%
5/17/2021	Nuveen Asset Management LLC	62,951	$1.53M	0.0%	-0.7%	0.174%
5/17/2021	Ikarian Capital LLC	153,941	$3.74M	0.1%	-47.6%	0.426%
5/17/2021	Goldman Sachs Group Inc.	84,528	$2.05M	0.0%	+17.0%	0.234%
5/14/2021	Tekla Capital Management LLC	131,990	$3.20M	0.1%	N/A	0.365%
5/14/2021	UBS Asset Management Americas Inc.	10,500	$0.26M	0.0%	+40.0%	0.029%
5/14/2021	Credit Suisse AG	9,293	$0.23M	0.0%	-61.0%	0.026%
5/13/2021	Trexquant Investment LP	11,748	$0.29M	0.0%	+11.6%	0.032%
5/13/2021	SG Americas Securities LLC	21,828	$0.53M	0.0%	+102.6%	0.060%
5/13/2021	Renaissance Technologies LLC	18,600	$0.45M	0.0%	N/A	0.051%
5/13/2021	Bank of New York Mellon Corp	61,474	$1.49M	0.0%	-3.2%	0.170%
5/13/2021	Citigroup Inc.	127,891	$3.10M	0.0%	+1,612.1%	0.354%
5/13/2021	Federated Hermes Inc.	875,952	$21.25M	0.0%	+46.0%	2.422%
5/13/2021	Aviva PLC	53,080	$1.29M	0.0%	N/A	0.147%
5/13/2021	Allianz Asset Management GmbH	10,405	$0.25M	0.0%	-71.3%	0.029%
5/12/2021	Northern Trust Corp	193,744	$4.70M	0.0%	-5.0%	0.536%
5/12/2021	Geode Capital Management LLC	297,437	$7.22M	0.0%	+10.2%	0.823%
5/12/2021	JPMorgan Chase & Co.	351,860	$8.54M	0.0%	-1.9%	0.974%
5/12/2021	E Fund Management Co. Ltd.	4,222	$0.10M	0.0%	N/A	0.012%
5/12/2021	UBS Group AG	43,189	$1.05M	0.0%	N/A	0.120%
5/12/2021	Bellevue Group AG	2,243,000	$54.42M	0.6%	+59.9%	6.207%
5/11/2021	Peregrine Capital Management LLC	184,253	$4.47M	0.1%	-12.2%	0.510%
5/10/2021	Rafferty Asset Management LLC	101,474	$2.46M	0.0%	+1,207.5%	0.281%
5/10/2021	GSA Capital Partners LLP	21,200	$0.51M	0.1%	N/A	0.059%
5/10/2021	Bank Julius Baer & Co. Ltd Zurich	35,000	$0.85M	0.0%	N/A	0.097%
5/7/2021	BlackRock Inc.	1,930,585	$46.84M	0.0%	+15.4%	5.342%
5/6/2021	Rhumbline Advisers	18,306	$0.44M	0.0%	-5.7%	0.051%
5/6/2021	Redmond Asset Management LLC	15,633	$0.38M	0.1%	N/A	0.043%
5/4/2021	Migdal Insurance & Financial Holdings Ltd.	20,770	$0.50M	0.0%	+163.5%	0.057%
5/4/2021	Victory Capital Management Inc.	10,203	$0.25M	0.0%	-5.3%	0.028%
4/29/2021	Hershey Trust Co.	12,836	$0.31M	0.0%	-50.6%	0.036%
4/5/2021	Pacer Advisors Inc.	2,369	$57K	0.0%	+116.7%	0.007%
3/26/2021	Susquehanna International Group LLP	9,504	$0.31M	0.0%	N/A	0.026%
3/12/2021	DekaBank Deutsche Girozentrale	12,400	$0.41M	0.0%	N/A	0.034%
3/2/2021	Norges Bank	100,000	$3.21M	0.0%	N/A	0.277%
3/1/2021	UBS Asset Management Americas Inc.	7,500	$0.24M	0.0%	N/A	0.021%
2/25/2021	Hsbc Holdings PLC	8,518	$0.27M	0.0%	N/A	0.024%
2/23/2021	Principal Financial Group Inc.	7,414	$0.24M	0.0%	N/A	0.021%
2/19/2021	JPMorgan Chase & Co.	358,853	$11.50M	0.0%	+76.0%	0.994%
2/17/2021	Jane Street Group LLC	18,620	$0.60M	0.0%	N/A	0.052%
2/16/2021	Squarepoint Ops LLC	30,434	$0.98M	0.0%	N/A	0.084%
2/16/2021	Tri Locum Partners LP	10,283	$0.33M	0.1%	N/A	0.028%
2/16/2021	Nuveen Asset Management LLC	63,392	$2.03M	0.0%	-3.3%	0.176%
2/16/2021	Avoro Capital Advisors LLC	640,000	$20.51M	0.4%	+6.2%	1.772%
2/16/2021	Charles Schwab Investment Management Inc.	108,127	$3.47M	0.0%	+1.5%	0.299%
2/16/2021	MPM Oncology Impact Management LP	43,615	$1.40M	0.2%	N/A	0.121%
2/12/2021	Penserra Capital Management LLC	825	$26K	0.0%	N/A	0.002%
2/12/2021	Federated Hermes Inc.	600,000	$19.23M	0.0%	+26.4%	1.661%
2/12/2021	The Manufacturers Life Insurance Company	10,960	$0.35M	0.0%	+9.3%	0.030%
2/12/2021	Ikarian Capital LLC	293,941	$9.42M	0.4%	-18.1%	0.814%
2/12/2021	Credit Suisse AG	23,802	$0.76M	0.0%	N/A	0.066%
2/11/2021	Trexquant Investment LP	10,529	$0.34M	0.0%	N/A	0.029%
2/11/2021	Northern Trust Corp	204,020	$6.54M	0.0%	-0.8%	0.565%
2/11/2021	Citigroup Inc.	7,470	$0.24M	0.0%	+161.6%	0.021%
2/11/2021	Artal Group S.A.	1,646,517	$52.77M	1.1%	+8.2%	4.559%
2/10/2021	Rhumbline Advisers	19,411	$0.62M	0.0%	+14.1%	0.054%
2/9/2021	Wells Fargo & Company MN	663,633	$21.27M	0.0%	+43.5%	1.838%
2/9/2021	Bank of New York Mellon Corp	63,539	$2.04M	0.0%	+8.4%	0.176%
2/9/2021	Lord Abbett & CO. LLC	261,918	$8.39M	0.0%	+70.2%	0.725%
2/9/2021	ProShare Advisors LLC	9,559	$0.31M	0.0%	N/A	0.026%
2/8/2021	Alliancebernstein L.P.	14,900	$0.48M	0.0%	+4.2%	0.041%
2/8/2021	New York State Common Retirement Fund	16,500	$0.53M	0.0%	+24.1%	0.046%
2/8/2021	HC Advisors LLC	8,467	$0.27M	0.2%	+26.8%	0.023%
2/6/2021	Jennison Associates LLC	364,416	$11.68M	0.0%	-1.1%	1.009%
2/5/2021	BlackRock Inc.	1,673,138	$53.62M	0.0%	+52.5%	4.633%
2/5/2021	Swiss National Bank	24,400	$0.78M	0.0%	+22.0%	0.068%
2/5/2021	SG Americas Securities LLC	10,775	$0.35M	0.0%	-78.6%	0.030%
2/4/2021	State of Wisconsin Investment Board	25,500	$0.82M	0.0%	+37.1%	0.071%
2/2/2021	TCW Group Inc.	166,318	$5.33M	0.0%	N/A	0.462%
2/1/2021	Victory Capital Management Inc.	10,770	$0.35M	0.0%	N/A	0.030%
1/21/2021	Hershey Trust Co.	25,984	$0.83M	0.0%	+214.7%	0.072%
1/20/2021	Pacer Advisors Inc.	1,093	$35K	0.0%	N/A	0.003%
1/19/2021	Peregrine Capital Management LLC	209,911	$6.73M	0.1%	+9.6%	0.583%
1/13/2021	Hamilton Lane Advisors LLC	14,644	$0.47M	0.2%	+46.7%	0.041%
12/30/2020	Deerfield Management Company L.P. Series C	802,511	$24.26M	0.5%	+49.7%	2.229%
12/4/2020	Sei Investments Co.	10,931	$0.33M	0.0%	N/A	0.030%
11/19/2020	Schonfeld Strategic Advisors LLC	8,100	$0.24M	0.0%	N/A	0.023%
11/17/2020	California State Teachers Retirement System	27,363	$0.83M	0.0%	+49.2%	0.076%
11/16/2020	Boothbay Fund Management LLC	42,874	$1.30M	0.1%	+94.6%	0.119%
11/16/2020	Amia Capital LLP	7,589	$0.23M	0.3%	+55.3%	0.021%
11/13/2020	Morgan Stanley	8,511	$0.26M	0.0%	+123.0%	0.024%
11/13/2020	Vivo Capital LLC	145,417	$4.40M	0.3%	-3.3%	0.405%
11/13/2020	Charles Schwab Investment Management Inc.	106,569	$3.22M	0.0%	+31.2%	0.297%
11/13/2020	Virtus ETF Advisers LLC	8,920	$0.27M	0.1%	-12.0%	0.025%
11/12/2020	HarbourVest Partners LLC	9,581	$0.29M	0.1%	N/A	0.027%
11/12/2020	JPMorgan Chase & Co.	203,942	$6.20M	0.0%	+176.7%	0.568%
11/12/2020	Lord Abbett & CO. LLC	153,851	$4.65M	0.0%	-6.1%	0.428%
11/10/2020	State Street Corp	278,919	$8.43M	0.0%	+21.2%	0.777%
11/9/2020	SG Americas Securities LLC	50,325	$1.52M	0.0%	+576.3%	0.140%
11/9/2020	The Manufacturers Life Insurance Company	10,031	$0.30M	0.0%	+41.7%	0.028%

Data available starting January 2016

Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an irreversible small molecule inhibitor that is designed to block the function of family of oncogenic proteins defined by driver mutations across a range of tumor types, and which affect the epidermal growth factor receptor (EGFR), the tyrosine-protein kinase, or human epidermal growth factor receptor 2. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including allosteric and canonical EGFR mutations; and various early stage pipeline programs of allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $12.71

$12.42

$12.75

50 Day Range

MA: $19.44

$12.23

$28.17

52 Week Range

Now: $12.71

$11.93

$45.97

Volume

588,864 shs

Average Volume

627,476 shs

Market Capitalization

$459.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.51

Who are the company insiders with the largest holdings of Black Diamond Therapeutics?

Black Diamond Therapeutics' top insider shareholders include:

David M Epstein (Insider)
Bradley J Phd Bolzon (Director)
Brent Hatzis-Schoch (Insider)
Christopher D Roberts (Insider)
Robert Alexander Ingram (Director)
Thomas Leggett (CFO)
James E Flynn (Insider)
Rajeev M Shah (Director)
Versant Venture Capital Vi, L (Major Shareholder)

Who are the major institutional investors of Black Diamond Therapeutics?

Black Diamond Therapeutics' top institutional shareholders include:

Bellevue Group AG — 6.21%
BlackRock Inc. — 5.34%
Deerfield Management Company L.P. Series C — 2.90%
Federated Hermes Inc. — 2.42%
Polar Capital Holdings Plc — 1.53%
JPMorgan Chase & Co. — 0.97%

Which major investors are selling Black Diamond Therapeutics stock?

During the last quarter, BDTX stock was sold by these institutional investors:

Ikarian Capital LLC
Morgan Stanley
Millennium Management LLC
Allianz Asset Management GmbH
Peregrine Capital Management LLC
Credit Suisse AG
Hershey Trust Co.
Northern Trust Corp

In the previous year, company insiders that have sold Black Diamond Therapeutics company stock include:

David M Epstein (Insider)
Bradley J Phd Bolzon (Director)
Brent Hatzis-Schoch (Insider)
Christopher D Roberts (Insider)
Robert Alexander Ingram (Director)
Thomas Leggett (CFO)

Which major investors are buying Black Diamond Therapeutics stock?

In the last quarter, BDTX stock was bought by institutional investors including:

Bellevue Group AG
Federated Hermes Inc.
BlackRock Inc.
Deerfield Management Company L.P. Series C
Tekla Capital Management LLC
Citigroup Inc.
Rafferty Asset Management LLC
Polar Capital Holdings Plc

During the previous year, these company insiders have bought Black Diamond Therapeutics stock:

David M Epstein (Insider)
Bradley J Phd Bolzon (Director)
Brent Hatzis-Schoch (Insider)
Christopher D Roberts (Insider)

Man Who Retired at 42 Shares 3-Stock Method

From Legacy- JCF Campaigns | Ad

Jeff retired early by trading options using one simple method. Click here for full details